Herbalife Ltd. (HLF) financials: revenue, earnings and cash flow
Fiscal 2016–2025 + TTM · from SEC filings · data as of November 13, 2026
Summary
Herbalife’s revenue went from $4.5B in fiscal 2016 to $5.0B in fiscal 2025, growth of about 1.3% a year.
Net income in fiscal 2025 was $228M, a net margin of 4.5%; the best year in this period was 2021 with $447M.
Over the twelve months to September 30, 2026, revenue was $5.3B and net income $180M.
Free cash flow was $253M in fiscal 2025 and positive in 10 of the 10 years shown.
The diluted share count fell 40% over the period (buybacks).
Revenue, profit and cash flow by year
Income statement
| Fiscal year | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $5.3B | $5.0B | $5.0B | $5.1B | $5.2B | $5.8B | $5.5B | $4.9B | $4.9B | $4.4B | $4.5B |
| Gross profit | $4.1B | $3.9B | $3.9B | $3.9B | $4.0B | $4.6B | $4.4B | $3.9B | $4.0B | $3.6B | $3.6B |
| Operating income | $505M | $481M | $386M | $356M | $545M | $734M | $641M | $568M | $683M | $617M | $458M |
| Net income | $180M | $228M | $254M | $142M | $321M | $447M | $373M | $311M | $297M | $214M | $260M |
| EPS (diluted) | $1.69 | $2.20 | $2.50 | $1.42 | $3.23 | $4.13 | $2.77 | $2.20 | $1.98 | $1.29 | $1.51 |
| R&D | — | — | — | — | — | — | — | — | — | — | — |
| Revenue growth | — | +0.9% | −1.4% | −2.7% | −10.3% | +4.7% | +13.6% | −0.3% | +10.5% | −1.4% | +0.4% |
Cash flow
| Fiscal year | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $396M | $333M | $285M | $358M | $352M | $460M | $629M | $458M | $648M | $591M | $367M |
| Capital spending | -$59M | -$80M | -$122M | -$135M | -$156M | -$151M | -$112M | -$106M | -$84M | -$96M | -$143M |
| Free cash flow | $337M | $253M | $163M | $222M | $196M | $309M | $517M | $351M | $564M | $495M | $224M |
| Dividends paid | — | — | — | — | — | — | — | — | $0 | $0 | $0 |
| Buybacks | $10M | $8M | $8M | $11M | $147M | $1.0B | $924M | $17M | $750M | $844M | $13M |
| Stock-based pay | $40M | $44M | $50M | $48M | $44M | $54M | $51M | $39M | $36M | $42M | $40M |
Balance sheet
| Fiscal year | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash | — | $353M | $415M | $575M | $508M | $602M | $1.0B | $839M | $1.2B | $1.3B | $844M |
| Debt | — | $2.2B | $2.5B | $2.8B | $2.9B | $3.0B | $2.7B | $2.0B | $2.5B | $2.3B | $1.4B |
| Equity | — | -$515M | -$801M | -$1.1B | -$1.3B | -$1.4B | -$856M | -$390M | -$723M | -$335M | $196M |
| Total assets | — | $2.8B | $2.7B | $2.8B | $2.7B | $2.8B | $3.1B | $2.7B | $2.8B | $2.9B | $2.6B |
| Shares (diluted) | 107M | 104M | 102M | 100M | 100M | 108M | 134M | 142M | 150M | 166M | 172M |
Margins and returns
| Fiscal year | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross margin | 77.6% | 77.9% | 77.9% | 76.5% | 77.5% | 78.6% | 79.2% | 80.4% | 81.2% | 80.8% | 81.0% |
| Operating margin | 9.6% | 9.6% | 7.7% | 7.0% | 10.5% | 12.7% | 11.6% | 11.7% | 14.0% | 13.9% | 10.2% |
| Net margin | 3.4% | 4.5% | 5.1% | 2.8% | 6.2% | 7.7% | 6.7% | 6.4% | 6.1% | 4.8% | 5.8% |
| FCF margin | 6.4% | 5.0% | 3.3% | 4.4% | 3.8% | 5.3% | 9.3% | 7.2% | 11.5% | 11.2% | 5.0% |
| ROIC | — | 23.9% | 18.3% | 14.6% | 24.9% | 36.2% | 25.5% | 24.2% | 25.2% | 25.2% | 19.9% |
| ROE | — | -44.3% | -31.7% | -13.4% | -25.4% | -32.1% | -43.5% | -79.7% | -41.0% | -63.9% | 132.4% |
Frequently asked questions
What is Herbalife’s annual revenue?
$5.0B in fiscal 2025 and $5.3B over the twelve months to September 30, 2026.
How much profit does Herbalife make?
Net income was $228M in fiscal 2025 (net margin 4.5%).
Is Herbalife’s revenue growing?
Yes: revenue rose 0.9% in fiscal 2025 compared with the year before.
From the company’s 10-K and 10-Q filings with the SEC; per-share figures adjusted for stock splits. Rebuilt daily. Not investment advice.